FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Crisaborole 20 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
Crisaborole 20 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Dupilumab 150 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Dupilumab 150 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Secukinumab 150 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Secukinumab 150 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Fenfluramine 2.2 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Fenfluramine 2.2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Monomethyl fumarate 95 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
Monomethyl fumarate 95 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Monomethyl fumarate only product Count of base of active ingredient False un Inferred relationship Some
Monomethyl fumarate only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 4
Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value (attribute) False un Inferred relationship Some 2
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Clostridium histolyticum collagenase 900 microgram lyophilized powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Clostridium histolyticum collagenase 900 microgram lyophilized powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) Count of base of active ingredient False un Inferred relationship Some
Vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) Count of base of active ingredient False un Inferred relationship Some
Minocycline only product in cutaneous dose form Count of base of active ingredient False un Inferred relationship Some
Fenfluramine only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
Remdesivir 5 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Remdesivir 5 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Soybean oil refined only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
Soybean oil refined only product Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Carbon (13-C) urea only product Count of base of active ingredient False un Inferred relationship Some
Product containing only carbon (13-C) urea in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product Count of base of active ingredient False un Inferred relationship Some
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) Count of base of active ingredient False un Inferred relationship Some
Pneu-C-10 pneumocoque conjugué 10-valent non spécifié Count of base of active ingredient False un Inferred relationship Some
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product Count of active ingredient False un Inferred relationship Some
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
SARS-CoV-2 antigen vaccine Count of base of active ingredient False un Inferred relationship Some
Product containing only bamlanivimab (medicinal product) Count of base of active ingredient False un Inferred relationship Some
Bamlanivimab only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
COVID-19 messenger ribonucleic acid unspecified Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Atorvastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Cerivastatin sodium 800 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amisulpride 400 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely almotriptan malate 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amprenavir 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Alendronic acid 70 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Nateglinide 180 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Nateglinide 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Nateglinide 60 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Capecitabine 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Capecitabine 150 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aluminum hydroxide 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aluminum hydroxide 475 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Aluminum hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aluminum hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Atropine sulfate 600 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alverine citrate 120 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Alverine citrate 60 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Nizatidine 300 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely omeprazole 20 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole 40 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole 10 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Olsalazine sodium 250 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Olsalazine sodium 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Balsalazide disodium 750 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Methylcellulose-450 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Orlistat 120 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Bendroflumethiazide 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Bendroflumethiazide 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1

Start Previous Page 114 of 217 Next End

This concept is not in any reference sets

Back to Start